Accès ouvert
2020
erratum
OpenAlex
Aurélien Venara, Hélène Meillat, Eddy Cotte, Mehdi Ouaïssi et autres
In the list of participating investigators that appears in Acknowledgements, one of the investigators names appears incorrectly.
fr, be, ch
(code pays fourni par la source)
2019
article
OpenAlex
Aurélien Venara, Hélène Meillat, Eddy Cotte, Mehdi Ouaïssi et autres
BACKGROUND: Defining severe postoperative ileus in terms of consequences could help physicians standardize the management of this condition. The recently described classification based on consequences requires further investigation. The aim of this study was to obtain a snapshot of postoperative ileus in …
fr, be, ch
(code pays fourni par la source)
2016
article
OpenAlex
S Aissou, Cartier, A. Hamy, F. Plumereau et autres
BACKGROUND: Liver resection is the curative treatment for patients with colorectal liver metastases (CRLMs), with five-year survival rates of 30-50%. Radiofrequency ablation (RFA) is a local and useful alternative for patients with non-resectable CRLMs to obtain complete tumor clearance. The aim of …
fr
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
Jean-Pierre Barbieux, F. Plumereau, A. Hamy
fr
(code pays fourni par la source)
2016
article
OpenAlex
Jean-Pierre Barbieux, F. Plumereau, A. Hamy
fr
(code pays fourni par la source)
2015
article
OpenAlex
F. Plumereau, J. Barbieux, Émilie Lermite
fr
(code pays fourni par la source)
Accès ouvert
2015
article
OpenAlex
F. Plumereau, S. Mucci, P. Le Naoures, J.B. Finel et autres
fr
(code pays fourni par la source)
2015
article
OpenAlex
F. Plumereau, S. Mucci, P. Le Naoures, J.B. Finel et autres
fr
(code pays fourni par la source)
Accès ouvert
2014
article
OpenAlex
F. Plumereau, Frédéric Pinaud, Alexandra M. Roch, Christophe Baufreton
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether patients with haematological malignancy (HM) who need cardiopulmonary bypass (CPB) have a higher short-term mortality or a higher chance of disease progression secondary …
fr
(code pays fourni par la source)